By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy
- Home
- Medical Devices
- Report Detail
Highlights
The global Molecular Diagnostics in Point of Care market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Molecular Diagnostics in Point of Care is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Molecular Diagnostics in Point of Care is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Molecular Diagnostics in Point of Care in Hospitals and Clinics is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Molecular Diagnostics in Point of Care include Abbott, Accelerate Diagnostics, Ador Diagnostics, Beckman Coulter, Becton, Dickinson and Company, Binx Health, Biocartis, bioMérieux and Bio-Rad Laboratories, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostics in Point of Care, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostics in Point of Care.
The Molecular Diagnostics in Point of Care market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Molecular Diagnostics in Point of Care market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Diagnostics in Point of Care companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Abbott
- Accelerate Diagnostics
- Ador Diagnostics
- Beckman Coulter
- Becton, Dickinson and Company
- Binx Health
- Biocartis
- bioMérieux
- Bio-Rad Laboratories
- Bosch Healthcare Solutions
- Curetis
- Eurofins Scientific
- Genetic Signatures
- Grifols
- Hibergene Diagnostics
- Lumos Diagnostics
- Roche
- Siemens
- Thermo Fisher Scientific
Segment by Type
- Polymerase Chain Reaction
- In Situ Hybridization
- Gene Chips
- Next Generation Sequencing
Segment by Application
- Hospitals and Clinics
- Independent Clinical Laboratories
By Region
- North America
- - United States
- - Canada
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- - Nordic Countries
- - Rest of Europe
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Australia
- - Rest of Asia
- Latin America
- - Mexico
- - Brazil
- - Rest of Latin America
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - UAE
- - Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Diagnostics in Point of Care companies competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics in Point of Care Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Polymerase Chain Reaction
1.2.3 In Situ Hybridization
1.2.4 Gene Chips
1.2.5 Next Generation Sequencing
1.3 Market by Application
1.3.1 Global Molecular Diagnostics in Point of Care Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals and Clinics
1.3.3 Independent Clinical Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics in Point of Care Market Perspective (2018-2029)
2.2 Molecular Diagnostics in Point of Care Growth Trends by Region
2.2.1 Global Molecular Diagnostics in Point of Care Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Molecular Diagnostics in Point of Care Historic Market Size by Region (2018-2023)
2.2.3 Molecular Diagnostics in Point of Care Forecasted Market Size by Region (2024-2029)
2.3 Molecular Diagnostics in Point of Care Market Dynamics
2.3.1 Molecular Diagnostics in Point of Care Industry Trends
2.3.2 Molecular Diagnostics in Point of Care Market Drivers
2.3.3 Molecular Diagnostics in Point of Care Market Challenges
2.3.4 Molecular Diagnostics in Point of Care Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics in Point of Care Players by Revenue
3.1.1 Global Top Molecular Diagnostics in Point of Care Players by Revenue (2018-2023)
3.1.2 Global Molecular Diagnostics in Point of Care Revenue Market Share by Players (2018-2023)
3.2 Global Molecular Diagnostics in Point of Care Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics in Point of Care Revenue
3.4 Global Molecular Diagnostics in Point of Care Market Concentration Ratio
3.4.1 Global Molecular Diagnostics in Point of Care Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics in Point of Care Revenue in 2022
3.5 Molecular Diagnostics in Point of Care Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics in Point of Care Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics in Point of Care Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics in Point of Care Breakdown Data by Type
4.1 Global Molecular Diagnostics in Point of Care Historic Market Size by Type (2018-2023)
4.2 Global Molecular Diagnostics in Point of Care Forecasted Market Size by Type (2024-2029)
5 Molecular Diagnostics in Point of Care Breakdown Data by Application
5.1 Global Molecular Diagnostics in Point of Care Historic Market Size by Application (2018-2023)
5.2 Global Molecular Diagnostics in Point of Care Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Molecular Diagnostics in Point of Care Market Size (2018-2029)
6.2 North America Molecular Diagnostics in Point of Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Molecular Diagnostics in Point of Care Market Size by Country (2018-2023)
6.4 North America Molecular Diagnostics in Point of Care Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Diagnostics in Point of Care Market Size (2018-2029)
7.2 Europe Molecular Diagnostics in Point of Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Molecular Diagnostics in Point of Care Market Size by Country (2018-2023)
7.4 Europe Molecular Diagnostics in Point of Care Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics in Point of Care Market Size (2018-2029)
8.2 Asia-Pacific Molecular Diagnostics in Point of Care Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Molecular Diagnostics in Point of Care Market Size by Region (2018-2023)
8.4 Asia-Pacific Molecular Diagnostics in Point of Care Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics in Point of Care Market Size (2018-2029)
9.2 Latin America Molecular Diagnostics in Point of Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Molecular Diagnostics in Point of Care Market Size by Country (2018-2023)
9.4 Latin America Molecular Diagnostics in Point of Care Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics in Point of Care Market Size (2018-2029)
10.2 Middle East & Africa Molecular Diagnostics in Point of Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Molecular Diagnostics in Point of Care Market Size by Country (2018-2023)
10.4 Middle East & Africa Molecular Diagnostics in Point of Care Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Molecular Diagnostics in Point of Care Introduction
11.1.4 Abbott Revenue in Molecular Diagnostics in Point of Care Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 Accelerate Diagnostics
11.2.1 Accelerate Diagnostics Company Detail
11.2.2 Accelerate Diagnostics Business Overview
11.2.3 Accelerate Diagnostics Molecular Diagnostics in Point of Care Introduction
11.2.4 Accelerate Diagnostics Revenue in Molecular Diagnostics in Point of Care Business (2018-2023)
11.2.5 Accelerate Diagnostics Recent Development
11.3 Ador Diagnostics
11.3.1 Ador Diagnostics Company Detail
11.3.2 Ador Diagnostics Business Overview
11.3.3 Ador Diagnostics Molecular Diagnostics in Point of Care Introduction
11.3.4 Ador Diagnostics Revenue in Molecular Diagnostics in Point of Care Business (2018-2023)
11.3.5 Ador Diagnostics Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Detail
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Molecular Diagnostics in Point of Care Introduction
11.4.4 Beckman Coulter Revenue in Molecular Diagnostics in Point of Care Business (2018-2023)
11.4.5 Beckman Coulter Recent Development
11.5 Becton, Dickinson and Company
11.5.1 Becton, Dickinson and Company Company Detail
11.5.2 Becton, Dickinson and Company Business Overview
11.5.3 Becton, Dickinson and Company Molecular Diagnostics in Point of Care Introduction
11.5.4 Becton, Dickinson and Company Revenue in Molecular Diagnostics in Point of Care Business (2018-2023)
11.5.5 Becton, Dickinson and Company Recent Development
11.6 Binx Health
11.6.1 Binx Health Company Detail
11.6.2 Binx Health Business Overview
11.6.3 Binx Health Molecular Diagnostics in Point of Care Introduction
11.6.4 Binx Health Revenue in Molecular Diagnostics in Point of Care Business (2018-2023)
11.6.5 Binx Health Recent Development
11.7 Biocartis
11.7.1 Biocartis Company Detail
11.7.2 Biocartis Business Overview
11.7.3 Biocartis Molecular Diagnostics in Point of Care Introduction
11.7.4 Biocartis Revenue in Molecular Diagnostics in Point of Care Business (2018-2023)
11.7.5 Biocartis Recent Development
11.8 bioMérieux
11.8.1 bioMérieux Company Detail
11.8.2 bioMérieux Business Overview
11.8.3 bioMérieux Molecular Diagnostics in Point of Care Introduction
11.8.4 bioMérieux Revenue in Molecular Diagnostics in Point of Care Business (2018-2023)
11.8.5 bioMérieux Recent Development
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Detail
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Molecular Diagnostics in Point of Care Introduction
11.9.4 Bio-Rad Laboratories Revenue in Molecular Diagnostics in Point of Care Business (2018-2023)
11.9.5 Bio-Rad Laboratories Recent Development
11.10 Bosch Healthcare Solutions
11.10.1 Bosch Healthcare Solutions Company Detail
11.10.2 Bosch Healthcare Solutions Business Overview
11.10.3 Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Introduction
11.10.4 Bosch Healthcare Solutions Revenue in Molecular Diagnostics in Point of Care Business (2018-2023)
11.10.5 Bosch Healthcare Solutions Recent Development
11.11 Curetis
11.11.1 Curetis Company Detail
11.11.2 Curetis Business Overview
11.11.3 Curetis Molecular Diagnostics in Point of Care Introduction
11.11.4 Curetis Revenue in Molecular Diagnostics in Point of Care Business (2018-2023)
11.11.5 Curetis Recent Development
11.12 Eurofins Scientific
11.12.1 Eurofins Scientific Company Detail
11.12.2 Eurofins Scientific Business Overview
11.12.3 Eurofins Scientific Molecular Diagnostics in Point of Care Introduction
11.12.4 Eurofins Scientific Revenue in Molecular Diagnostics in Point of Care Business (2018-2023)
11.12.5 Eurofins Scientific Recent Development
11.13 Genetic Signatures
11.13.1 Genetic Signatures Company Detail
11.13.2 Genetic Signatures Business Overview
11.13.3 Genetic Signatures Molecular Diagnostics in Point of Care Introduction
11.13.4 Genetic Signatures Revenue in Molecular Diagnostics in Point of Care Business (2018-2023)
11.13.5 Genetic Signatures Recent Development
11.14 Grifols
11.14.1 Grifols Company Detail
11.14.2 Grifols Business Overview
11.14.3 Grifols Molecular Diagnostics in Point of Care Introduction
11.14.4 Grifols Revenue in Molecular Diagnostics in Point of Care Business (2018-2023)
11.14.5 Grifols Recent Development
11.15 Hibergene Diagnostics
11.15.1 Hibergene Diagnostics Company Detail
11.15.2 Hibergene Diagnostics Business Overview
11.15.3 Hibergene Diagnostics Molecular Diagnostics in Point of Care Introduction
11.15.4 Hibergene Diagnostics Revenue in Molecular Diagnostics in Point of Care Business (2018-2023)
11.15.5 Hibergene Diagnostics Recent Development
11.16 Lumos Diagnostics
11.16.1 Lumos Diagnostics Company Detail
11.16.2 Lumos Diagnostics Business Overview
11.16.3 Lumos Diagnostics Molecular Diagnostics in Point of Care Introduction
11.16.4 Lumos Diagnostics Revenue in Molecular Diagnostics in Point of Care Business (2018-2023)
11.16.5 Lumos Diagnostics Recent Development
11.17 Roche
11.17.1 Roche Company Detail
11.17.2 Roche Business Overview
11.17.3 Roche Molecular Diagnostics in Point of Care Introduction
11.17.4 Roche Revenue in Molecular Diagnostics in Point of Care Business (2018-2023)
11.17.5 Roche Recent Development
11.18 Siemens
11.18.1 Siemens Company Detail
11.18.2 Siemens Business Overview
11.18.3 Siemens Molecular Diagnostics in Point of Care Introduction
11.18.4 Siemens Revenue in Molecular Diagnostics in Point of Care Business (2018-2023)
11.18.5 Siemens Recent Development
11.19 Thermo Fisher Scientific
11.19.1 Thermo Fisher Scientific Company Detail
11.19.2 Thermo Fisher Scientific Business Overview
11.19.3 Thermo Fisher Scientific Molecular Diagnostics in Point of Care Introduction
11.19.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics in Point of Care Business (2018-2023)
11.19.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Molecular Diagnostics in Point of Care Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Polymerase Chain Reaction
Table 3. Key Players of In Situ Hybridization
Table 4. Key Players of Gene Chips
Table 5. Key Players of Next Generation Sequencing
Table 6. Global Molecular Diagnostics in Point of Care Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Molecular Diagnostics in Point of Care Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Molecular Diagnostics in Point of Care Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Molecular Diagnostics in Point of Care Market Share by Region (2018-2023)
Table 10. Global Molecular Diagnostics in Point of Care Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Molecular Diagnostics in Point of Care Market Share by Region (2024-2029)
Table 12. Molecular Diagnostics in Point of Care Market Trends
Table 13. Molecular Diagnostics in Point of Care Market Drivers
Table 14. Molecular Diagnostics in Point of Care Market Challenges
Table 15. Molecular Diagnostics in Point of Care Market Restraints
Table 16. Global Molecular Diagnostics in Point of Care Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Molecular Diagnostics in Point of Care Market Share by Players (2018-2023)
Table 18. Global Top Molecular Diagnostics in Point of Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics in Point of Care as of 2022)
Table 19. Ranking of Global Top Molecular Diagnostics in Point of Care Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Molecular Diagnostics in Point of Care Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Molecular Diagnostics in Point of Care Product Solution and Service
Table 23. Date of Enter into Molecular Diagnostics in Point of Care Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Molecular Diagnostics in Point of Care Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Molecular Diagnostics in Point of Care Revenue Market Share by Type (2018-2023)
Table 27. Global Molecular Diagnostics in Point of Care Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Molecular Diagnostics in Point of Care Revenue Market Share by Type (2024-2029)
Table 29. Global Molecular Diagnostics in Point of Care Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Molecular Diagnostics in Point of Care Revenue Market Share by Application (2018-2023)
Table 31. Global Molecular Diagnostics in Point of Care Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Molecular Diagnostics in Point of Care Revenue Market Share by Application (2024-2029)
Table 33. North America Molecular Diagnostics in Point of Care Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Molecular Diagnostics in Point of Care Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Molecular Diagnostics in Point of Care Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Molecular Diagnostics in Point of Care Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Molecular Diagnostics in Point of Care Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Molecular Diagnostics in Point of Care Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Molecular Diagnostics in Point of Care Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Molecular Diagnostics in Point of Care Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Molecular Diagnostics in Point of Care Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Molecular Diagnostics in Point of Care Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Molecular Diagnostics in Point of Care Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Molecular Diagnostics in Point of Care Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Molecular Diagnostics in Point of Care Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Molecular Diagnostics in Point of Care Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Molecular Diagnostics in Point of Care Market Size by Country (2024-2029) & (US$ Million)
Table 48. Abbott Company Detail
Table 49. Abbott Business Overview
Table 50. Abbott Molecular Diagnostics in Point of Care Product
Table 51. Abbott Revenue in Molecular Diagnostics in Point of Care Business (2018-2023) & (US$ Million)
Table 52. Abbott Recent Development
Table 53. Accelerate Diagnostics Company Detail
Table 54. Accelerate Diagnostics Business Overview
Table 55. Accelerate Diagnostics Molecular Diagnostics in Point of Care Product
Table 56. Accelerate Diagnostics Revenue in Molecular Diagnostics in Point of Care Business (2018-2023) & (US$ Million)
Table 57. Accelerate Diagnostics Recent Development
Table 58. Ador Diagnostics Company Detail
Table 59. Ador Diagnostics Business Overview
Table 60. Ador Diagnostics Molecular Diagnostics in Point of Care Product
Table 61. Ador Diagnostics Revenue in Molecular Diagnostics in Point of Care Business (2018-2023) & (US$ Million)
Table 62. Ador Diagnostics Recent Development
Table 63. Beckman Coulter Company Detail
Table 64. Beckman Coulter Business Overview
Table 65. Beckman Coulter Molecular Diagnostics in Point of Care Product
Table 66. Beckman Coulter Revenue in Molecular Diagnostics in Point of Care Business (2018-2023) & (US$ Million)
Table 67. Beckman Coulter Recent Development
Table 68. Becton, Dickinson and Company Company Detail
Table 69. Becton, Dickinson and Company Business Overview
Table 70. Becton, Dickinson and Company Molecular Diagnostics in Point of Care Product
Table 71. Becton, Dickinson and Company Revenue in Molecular Diagnostics in Point of Care Business (2018-2023) & (US$ Million)
Table 72. Becton, Dickinson and Company Recent Development
Table 73. Binx Health Company Detail
Table 74. Binx Health Business Overview
Table 75. Binx Health Molecular Diagnostics in Point of Care Product
Table 76. Binx Health Revenue in Molecular Diagnostics in Point of Care Business (2018-2023) & (US$ Million)
Table 77. Binx Health Recent Development
Table 78. Biocartis Company Detail
Table 79. Biocartis Business Overview
Table 80. Biocartis Molecular Diagnostics in Point of Care Product
Table 81. Biocartis Revenue in Molecular Diagnostics in Point of Care Business (2018-2023) & (US$ Million)
Table 82. Biocartis Recent Development
Table 83. bioMérieux Company Detail
Table 84. bioMérieux Business Overview
Table 85. bioMérieux Molecular Diagnostics in Point of Care Product
Table 86. bioMérieux Revenue in Molecular Diagnostics in Point of Care Business (2018-2023) & (US$ Million)
Table 87. bioMérieux Recent Development
Table 88. Bio-Rad Laboratories Company Detail
Table 89. Bio-Rad Laboratories Business Overview
Table 90. Bio-Rad Laboratories Molecular Diagnostics in Point of Care Product
Table 91. Bio-Rad Laboratories Revenue in Molecular Diagnostics in Point of Care Business (2018-2023) & (US$ Million)
Table 92. Bio-Rad Laboratories Recent Development
Table 93. Bosch Healthcare Solutions Company Detail
Table 94. Bosch Healthcare Solutions Business Overview
Table 95. Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Product
Table 96. Bosch Healthcare Solutions Revenue in Molecular Diagnostics in Point of Care Business (2018-2023) & (US$ Million)
Table 97. Bosch Healthcare Solutions Recent Development
Table 98. Curetis Company Detail
Table 99. Curetis Business Overview
Table 100. Curetis Molecular Diagnostics in Point of Care Product
Table 101. Curetis Revenue in Molecular Diagnostics in Point of Care Business (2018-2023) & (US$ Million)
Table 102. Curetis Recent Development
Table 103. Eurofins Scientific Company Detail
Table 104. Eurofins Scientific Business Overview
Table 105. Eurofins Scientific Molecular Diagnostics in Point of Care Product
Table 106. Eurofins Scientific Revenue in Molecular Diagnostics in Point of Care Business (2018-2023) & (US$ Million)
Table 107. Eurofins Scientific Recent Development
Table 108. Genetic Signatures Company Detail
Table 109. Genetic Signatures Business Overview
Table 110. Genetic Signatures Molecular Diagnostics in Point of Care Product
Table 111. Genetic Signatures Revenue in Molecular Diagnostics in Point of Care Business (2018-2023) & (US$ Million)
Table 112. Genetic Signatures Recent Development
Table 113. Grifols Company Detail
Table 114. Grifols Business Overview
Table 115. Grifols Molecular Diagnostics in Point of Care Product
Table 116. Grifols Revenue in Molecular Diagnostics in Point of Care Business (2018-2023) & (US$ Million)
Table 117. Grifols Recent Development
Table 118. Hibergene Diagnostics Company Detail
Table 119. Hibergene Diagnostics Business Overview
Table 120. Hibergene Diagnostics Molecular Diagnostics in Point of Care Product
Table 121. Hibergene Diagnostics Revenue in Molecular Diagnostics in Point of Care Business (2018-2023) & (US$ Million)
Table 122. Hibergene Diagnostics Recent Development
Table 123. Lumos Diagnostics Company Detail
Table 124. Lumos Diagnostics Business Overview
Table 125. Lumos Diagnostics Molecular Diagnostics in Point of Care Product
Table 126. Lumos Diagnostics Revenue in Molecular Diagnostics in Point of Care Business (2018-2023) & (US$ Million)
Table 127. Lumos Diagnostics Recent Development
Table 128. Roche Company Detail
Table 129. Roche Business Overview
Table 130. Roche Molecular Diagnostics in Point of Care Product
Table 131. Roche Revenue in Molecular Diagnostics in Point of Care Business (2018-2023) & (US$ Million)
Table 132. Roche Recent Development
Table 133. Siemens Company Detail
Table 134. Siemens Business Overview
Table 135. Siemens Molecular Diagnostics in Point of Care Product
Table 136. Siemens Revenue in Molecular Diagnostics in Point of Care Business (2018-2023) & (US$ Million)
Table 137. Siemens Recent Development
Table 138. Thermo Fisher Scientific Company Detail
Table 139. Thermo Fisher Scientific Business Overview
Table 140. Thermo Fisher Scientific Molecular Diagnostics in Point of Care Product
Table 141. Thermo Fisher Scientific Revenue in Molecular Diagnostics in Point of Care Business (2018-2023) & (US$ Million)
Table 142. Thermo Fisher Scientific Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnostics in Point of Care Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Molecular Diagnostics in Point of Care Market Share by Type: 2022 VS 2029
Figure 3. Polymerase Chain Reaction Features
Figure 4. In Situ Hybridization Features
Figure 5. Gene Chips Features
Figure 6. Next Generation Sequencing Features
Figure 7. Global Molecular Diagnostics in Point of Care Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Molecular Diagnostics in Point of Care Market Share by Application: 2022 VS 2029
Figure 9. Hospitals and Clinics Case Studies
Figure 10. Independent Clinical Laboratories Case Studies
Figure 11. Molecular Diagnostics in Point of Care Report Years Considered
Figure 12. Global Molecular Diagnostics in Point of Care Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Molecular Diagnostics in Point of Care Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Molecular Diagnostics in Point of Care Market Share by Region: 2022 VS 2029
Figure 15. Global Molecular Diagnostics in Point of Care Market Share by Players in 2022
Figure 16. Global Top Molecular Diagnostics in Point of Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics in Point of Care as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Molecular Diagnostics in Point of Care Revenue in 2022
Figure 18. North America Molecular Diagnostics in Point of Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Molecular Diagnostics in Point of Care Market Share by Country (2018-2029)
Figure 20. United States Molecular Diagnostics in Point of Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Molecular Diagnostics in Point of Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Molecular Diagnostics in Point of Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Molecular Diagnostics in Point of Care Market Share by Country (2018-2029)
Figure 24. Germany Molecular Diagnostics in Point of Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Molecular Diagnostics in Point of Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Molecular Diagnostics in Point of Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Molecular Diagnostics in Point of Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Molecular Diagnostics in Point of Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Molecular Diagnostics in Point of Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Molecular Diagnostics in Point of Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Molecular Diagnostics in Point of Care Market Share by Region (2018-2029)
Figure 32. China Molecular Diagnostics in Point of Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Molecular Diagnostics in Point of Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Molecular Diagnostics in Point of Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Molecular Diagnostics in Point of Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Molecular Diagnostics in Point of Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Molecular Diagnostics in Point of Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Molecular Diagnostics in Point of Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Molecular Diagnostics in Point of Care Market Share by Country (2018-2029)
Figure 40. Mexico Molecular Diagnostics in Point of Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Molecular Diagnostics in Point of Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Molecular Diagnostics in Point of Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Molecular Diagnostics in Point of Care Market Share by Country (2018-2029)
Figure 44. Turkey Molecular Diagnostics in Point of Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Molecular Diagnostics in Point of Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Abbott Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2018-2023)
Figure 47. Accelerate Diagnostics Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2018-2023)
Figure 48. Ador Diagnostics Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2018-2023)
Figure 49. Beckman Coulter Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2018-2023)
Figure 50. Becton, Dickinson and Company Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2018-2023)
Figure 51. Binx Health Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2018-2023)
Figure 52. Biocartis Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2018-2023)
Figure 53. bioMérieux Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2018-2023)
Figure 54. Bio-Rad Laboratories Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2018-2023)
Figure 55. Bosch Healthcare Solutions Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2018-2023)
Figure 56. Curetis Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2018-2023)
Figure 57. Eurofins Scientific Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2018-2023)
Figure 58. Genetic Signatures Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2018-2023)
Figure 59. Grifols Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2018-2023)
Figure 60. Hibergene Diagnostics Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2018-2023)
Figure 61. Lumos Diagnostics Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2018-2023)
Figure 62. Roche Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2018-2023)
Figure 63. Siemens Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2018-2023)
Figure 64. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Write comment about above report:
Related Reports
|
Global Point of Care Molecular Diagnostics Technology Market Research Report 2023
Highlights The global Point of Care Molecular Diagnostics Technology market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-... |
|
Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Analyzers, Service), Application (Respiratory Diseases, HAIs, STDs, Cancer, Hepatitis), Technology (RT-PCR, INAAT), End User (Physician Office, Hospitals, ICUs) - Global Forecast to 2026
“Increasing prevalence of infectious diseases and cancer and the rising funding for R&D are driving the overall growth of the point-of-care molecular diagnostics market” The global point-of... |
|
Global Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Research Report 2021 - Impact of COVID-19 on the Market
The Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 202... |
|
2022-2029 Global Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Professional Market Research Report, Analysis from Perspective of Segmentation (Competitor Landscape, Type, Application, and Geography)
The Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology market has witnessed growth from USD XX million to USD XX million from 2017 to 2022. With the CAGR of X.X%, this market is estimated to reach USD XX m... |
|
2022-2029 Global Molecular Diagnostics (MDx) Point of Care Professional Market Research Report, Analysis from Perspective of Segmentation (Competitor Landscape, Type, Application, and Geography)
The Molecular Diagnostics (MDx) Point of Care market has witnessed growth from USD XX million to USD XX million from 2017 to 2022. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029. The report focuses on t... |
|
Global Molecular Diagnostics in Point of Care Market Research Report 2022
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostics in Point of Care, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competiti... |
|
Global Point of Care Molecular Diagnostics Technology Market Research Report 2022
This report aims to provide a comprehensive presentation of the global market for Point of Care Molecular Diagnostics Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market c... |
|
Global Molecular Diagnostics (MDx) Point of Care Market Research Report 2022 - Market Size, Current Insights and Development Trends
The report focuses on the Molecular Diagnostics (MDx) Point of Care market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the re... |
|
Global Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology Market Research Report 2022 - Market Size, Current Insights and Development Trends
The report focuses on the Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology market size, segment size (mainly covering product type, application, and geography), competitor landscape, rece... |
|
Global Point-of-Care Molecular Diagnostics Market 2022-2028
According to Gen Consulting Company, the global point-of-care molecular diagnostics market is set to achieve an incremental growth of USD 12.3 billion, acelerating at a CAGR of almost 14.7% during the forecast period 2022-2028. The repor... |
We are on:
Why ReportsnReports.com?
- 500,000 market research reports and growing.
- Top Fortune 500 Organizations trust us for research data.
- 24/7 support on call as well as emails.
- Your Details are safe with us.
- Free support for your research requirements.
- Report Delivery: Email
- Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays